Filters
For elderly patients with mild-moderate aortic stenosis, calcium supplementation with or without vitamin D may lead to unfavourable outcomes, such as lower survival and increased risk of aortic valve replacement, according to a study.
Neurosurgery performed 2–4 hours after presenting to the emergency department (ED) seems to result in better survival outcomes in patients with spontaneous haemorrhagic stroke, reports a recent study.
Breast arterial calcification (BAC), as viewed on screening mammograms, may suggest a risk of cardiovascular disease (CVD) in postmenopausal women, a recent US-based study showed.
Treatment with sacubitril/valsartan appears to improve right ventricular performance and pulmonary hypertension among patients with heart failure with reduced ejection fraction (HFrEF), independent of the reverse remodelling of the left ventricle, as reported in a study.
A systematic Mendelian randomization study has identified several modifiable cardiovascular disease (CVD) causal risk factors, including hypertension, smoking, and high body mass index.
A higher platelet response in middle-aged individuals who are free of antiplatelet therapy carries an increased risk of dementia in late life, according to a cohort study with 20 years of follow up.
Cardiorespiratory fitness (CRF) and inflammation are both independently linked to sudden cardiac death (SCD) in middle-aged men, reports a recent study. However, better CRF seems to offset the impact of inflammation on SCD risk.
New drug applications approved by US FDA as of 16-30 April 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Female patients nonvalvular atrial fibrillation (AF) are less often prescribed guideline-recommended oral anticoagulation at the emergency department (ED), which in turn contributes to an increased stroke risk at 1 year regardless of discharge status, a study has found.
Hot on the heels of ACC.22 ground-breaking reports, the ACC/AHA/HFSA* released the 2022 heart failure (HF) guideline, with special emphasis on quad therapy for patients with reduced ejection fraction.
